Pyxis Oncology prices $110 million offering with warrants for cancer drug development
AI Summary- Pyxis Oncology priced a registered offering of shares, pre-funded warrants and accompanying common warrants.
- $110 million is the expected gross offering proceeds before discounts, commissions and expenses.
- Pyxis expects closing around October 1, 2026, subject to customary closing conditions.